Skip to main content
. 2023 Feb 23;18(2):e0280926. doi: 10.1371/journal.pone.0280926

Table 2. Severity of symptoms at enrolment into WATCH trial (baseline) compared with primary endpoint time (day 7), stratified by AOM resolution at Day 7.

Symptoms
(’a lot’)
AOM resolution at day 7
(n = 113)
Persistent AOM at day 7
(n = 75)
Baseline
n (%)
day 7
n (%)
Relative change from baseline (%) Baseline
n (%)
day 7
n (%)
Relative change from baseline (%)
Runny nose 55 (48.7) 9 (8.0) -84 29 (38.7) 10 (13.3) -66
Coughing 49 (43.4) 10 (8.8) -80 29 (38.7) 13 (17.3) -55
Irritable/fussy 45 (39.8) 5 (4.4) -89 26 (34.7) 8 (10.7) -69
Difficulty sleeping 37 (32.7) 5 (4.4) -86 21 (28.0) 4 (5.3) -81
Crying 33 (29.2) 7 (6.2) -79 15 (20.0) 3 (4.0) -80
Tugging, rubbing ears 32 (28.3) 2 (1.8) -94 12 (16.0) 7 (9.3) -42
Ear pain 28 (24.8) 0 (0.0) -100 21 (28.0) 8 (10.7) -62
Fever 22 (19.5) 4 (3.5) -82 7 (9.3) 4 (5.3) -43
Eating less 19 (16.8) 4 (3.5) -79 18 (24.0) 2 (2.7) -89
Less playful 14 (12.4) 4 (3.5) -71 6 (8.0) 1 (1.3) -83
Vomiting 3 (2.7) 1 (0.9) -67 1 (1.3) 1 (1.3) 0
Diarrhoea 2 (1.8) 1 (0.9) -50 0 (0.0) 1 (1.3) N/A
Rash 1 (0.9) 1 (0.9) 0 1 (1.3) 2 (2.7) 100

N/A = not applicable